Major Adverse Cardiovascular Event Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting major adverse cardiovascular event clinical trials across 3 countries. Studies span Not Applicable. Top locations include Hong Kong, Hong Kong, Beijing, Beijing Municipality, China, Linyi, Shandong, China. Updated daily from ClinicalTrials.gov.


Major Adverse Cardiovascular Event Trials at a Glance

7 actively recruiting trials for major adverse cardiovascular event are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Hong Kong, Beijing, and Linyi. Lead sponsors running major adverse cardiovascular event studies include Chinese University of Hong Kong, Beijing Anzhen Hospital, and Centre Hospitalier Universitaire, Amiens.

Browse major adverse cardiovascular event trials by phase

Treatments under study

About Major Adverse Cardiovascular Event Clinical Trials

Looking for clinical trials for Major Adverse Cardiovascular Event? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Major Adverse Cardiovascular Event trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Major Adverse Cardiovascular Event clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Peripheral Artery DiseaseMajor Adverse Cardiovascular EventsMajor Adverse Limb Events+2 more
Centre Hospitalier Universitaire, Amiens134 enrolled1 locationNCT06318767
Recruiting

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

Major Adverse Cardiovascular EventsLeft Ventricular RemodelingPlasma Multi-Omics+2 more
Beijing Anzhen Hospital1,000 enrolled1 locationNCT06885619
Recruiting
Not Applicable

Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease

PreventionCoronary Artery Disease (CAD)Major Adverse Cardiovascular Events (MACE)+1 more
Zhang longjiang,MD3,100 enrolled1 locationNCT06843005
Recruiting

Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific

Brain DiseasesStroke, IschemicStroke+3 more
Chinese University of Hong Kong350 enrolled3 locationsNCT05578300
Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

DementiaBrain DiseasesStroke, Ischemic+7 more
Chinese University of Hong Kong500 enrolled1 locationNCT04992195
Recruiting

DOAC in Chinese Patients With Atrial Fibrillation

Brain DiseasesAtrial FibrillationStroke+4 more
Chinese University of Hong Kong427 enrolled1 locationNCT05378035
Recruiting

CCTA Improves Clinical Management of Stable Chest Pain

Stable chest painCoronary Artery DiseaseRevascularization+4 more
Tianjin Chest Hospital50,000 enrolled4 locationsNCT04691037